Table 1. Summary of responses to questionnaire regarding acceptability of injection therapy that would retard the progression of disease.
The survey was completed by 33 patients.
| Extremely or very
likely accept: |
Patients with
early Dupuytren’s disease (n=15) |
Patients who had previously
undergone surgery for Dupuytren’s disease (n=18) |
Both cohorts
combined (n=33) |
|---|---|---|---|
| 1 injection per year
for lifetime |
14 (93%) | 17 (94%) | 31 (94%) |
| 3 injections per
year for lifetime |
9 (60%) | 12 (67%) | 21 (64%) |